428 related articles for article (PubMed ID: 17680350)
21. Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas.
Asano TK; McLeod RS
Cochrane Database Syst Rev; 2004; 2004(2):CD004079. PubMed ID: 15106236
[TBL] [Abstract][Full Text] [Related]
22. [Chemoprevention of familial cancer].
Ishikawa H
Gan To Kagaku Ryoho; 1997 Jun; 24(8):951-7. PubMed ID: 9212803
[TBL] [Abstract][Full Text] [Related]
23. Chemoprevention in colorectal neoplasias: what is practical and feasible?
Ricciardiello L; Roda E; Bazzoli F
Dig Dis; 2002; 20(1):70-2. PubMed ID: 12145422
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of carcinogenesis in familial tumors.
Ishikawa H
Int J Clin Oncol; 2004 Aug; 9(4):299-303. PubMed ID: 15375706
[TBL] [Abstract][Full Text] [Related]
25. Colon cancer: preventive agents and the present status of chemoprevention.
Half E; Arber N
Expert Opin Pharmacother; 2009 Feb; 10(2):211-9. PubMed ID: 19236194
[TBL] [Abstract][Full Text] [Related]
26. Pharmacotherapy for inherited colorectal cancer.
Lynch PM
Expert Opin Pharmacother; 2010 May; 11(7):1101-8. PubMed ID: 20345333
[TBL] [Abstract][Full Text] [Related]
27. Chemoprevention strategies using NSAIDs and COX-2 inhibitors.
Keller JJ; Giardiello FM
Cancer Biol Ther; 2003; 2(4 Suppl 1):S140-9. PubMed ID: 14508092
[TBL] [Abstract][Full Text] [Related]
28. Chemoprevention of colorectal cancer.
Gwyn K; Sinicrope FA
Am J Gastroenterol; 2002 Jan; 97(1):13-21. PubMed ID: 11808936
[TBL] [Abstract][Full Text] [Related]
29. Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
Hilmi I; Goh KL
Chin J Dig Dis; 2006; 7(1):1-6. PubMed ID: 16412030
[TBL] [Abstract][Full Text] [Related]
30. Chemoprevention of colorectal neoplasia.
Wakeman C; Keenan J; Eteuati J; Hollington P; Eglinton T; Frizelle F
ANZ J Surg; 2017 Dec; 87(12):E228-E232. PubMed ID: 26686322
[TBL] [Abstract][Full Text] [Related]
31. Chemoprevention of colorectal neoplasia: the potential for personalized medicine.
Arber N; Levin B
Gastroenterology; 2008 Apr; 134(4):1224-37. PubMed ID: 18395100
[TBL] [Abstract][Full Text] [Related]
32. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.
DuBois RN; Giardiello FM; Smalley WE
Gastroenterol Clin North Am; 1996 Dec; 25(4):773-91. PubMed ID: 8960892
[TBL] [Abstract][Full Text] [Related]
33. Celecoxib for the prevention of sporadic colorectal adenomas.
Bertagnolli MM; Eagle CJ; Zauber AG; Redston M; Solomon SD; Kim K; Tang J; Rosenstein RB; Wittes J; Corle D; Hess TM; Woloj GM; Boisserie F; Anderson WF; Viner JL; Bagheri D; Burn J; Chung DC; Dewar T; Foley TR; Hoffman N; Macrae F; Pruitt RE; Saltzman JR; Salzberg B; Sylwestrowicz T; Gordon GB; Hawk ET;
N Engl J Med; 2006 Aug; 355(9):873-84. PubMed ID: 16943400
[TBL] [Abstract][Full Text] [Related]
34. [Non-steroidal anti-inflammatory agents and prevention of colorectal adenomas and carcinomas].
Raskov HH
Ugeskr Laeger; 2006 Jan; 168(4):359-62. PubMed ID: 16436235
[No Abstract] [Full Text] [Related]
35. Is the demonstration of adenoma reduction with rofecoxib a pyrrhic victory?
Lynch PM
Gastroenterology; 2006 Dec; 131(6):2003-5. PubMed ID: 17188962
[No Abstract] [Full Text] [Related]
36. Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.
Hisamuddin IM; Wehbi MA; Chao A; Wyre HW; Hylind LM; Giardiello FM; Yang VW
Clin Cancer Res; 2004 Dec; 10(24):8357-62. PubMed ID: 15623613
[TBL] [Abstract][Full Text] [Related]
37. Of timing and surrogates: a way forward for cancer chemoprevention.
Thompson PA; Gerner EW
Clin Cancer Res; 2011 Jun; 17(11):3509-11. PubMed ID: 21498391
[TBL] [Abstract][Full Text] [Related]
38. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
[TBL] [Abstract][Full Text] [Related]
39. [Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis].
Sheng JQ; Li SR; Yang XY; Zhang YH; Su H; Yu DL; Yan W; Geng HG
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):526-9. PubMed ID: 16681880
[TBL] [Abstract][Full Text] [Related]
40. Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications.
Chu AJ; Chou TH; Chen BD
Front Biosci; 2004 Sep; 9():2697-713. PubMed ID: 15353307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]